The adjunctive effect of nebulized furosemide in COPD exacerbation: a randomized controlled clinical trial.

@article{Vahedi2013TheAE,
  title={The adjunctive effect of nebulized furosemide in COPD exacerbation: a randomized controlled clinical trial.},
  author={Hojat Sheikh Motahar Vahedi and Babak Mahshidfar and Helaleh Rabiee and Soheil Saadat and Hamid Shokoohi and Mojtaba Chardoli and Vafa Rahimi-Movaghar},
  journal={Respiratory care},
  year={2013},
  volume={58 11},
  pages={1873-7}
}
OBJECTIVE To examine the effect of nebulized furosemide as an adjunct to the conventional treatment of patients with COPD exacerbation in an emergency department. METHODS In this randomized double-blinded clinical trial, patients with COPD exacerbation were randomized to receive 40 mg nebulized furosemide or placebo as an adjunct to the conventional… CONTINUE READING